businesswire | August 24, 2023
Press Ganey, the renowned leader in transforming the Human Experience (HX) across the healthcare ecosystem of patient, employee, member, and consumer journeys, announced a strategic partnership with Ardent Health Services, a leading healthcare provider with 30 hospitals, more than 200 sites of care and 1,400 aligned providers across six states.
The two organizations aim to redefine the Human Experience of healthcare and accelerate the drive toward zero harm. Bolstered by a shared commitment to safety, quality, and patient experience, the partnership leverages Press Ganey's Human Experience platform to pioneer advancements across the continuum of care.
Ardent’s relationship with Press Ganey underscores their shared vision for a safer, more human-focused era of healthcare. Through this collaboration, Ardent will harness Press Ganey's industry-leading Human Experience platform, fostering a proactive and holistic approach to healthcare excellence and innovation.
“Ardent’s partnership with Press Ganey aligns with our commitment to caring for others and a culture of safety through our MissionZERO initiative,” said Marty Bonick, President and CEO of Ardent. “As part of our journey to become a highly reliable organization, we hold ourselves to the highest standard of patient care and recognize Press Ganey as a true partner in this endeavor. Together, we understand that the people we serve are at the center of all we do. That is the Human Experience."
Press Ganey's approach to patient experience and safety aligns seamlessly with Ardent's commitment to innovation and its MissionZERO imperative. Through the partnership, both organizations will push the envelope of healthcare transformation, leading the charge toward a future marked by exceptional patient outcomes and a culture of high reliability.
"We are honored to stand side by side with Ardent in their unwavering resolve to achieve MissionZERO. Our mutual dedication to advancing the Human Experience in healthcare is a powerful catalyst for positive transformation," said Patrick T. Ryan, Chairman and CEO of Press Ganey. "This partnership reinforces our firm belief that every patient deserves the highest level of care and safety, and an experience defined by compassion."
About Press Ganey
Press Ganey, the leading Human Experience (HX) healthcare performance improvement company, offers an integrated suite of solutions that address safety, clinical excellence, patient and member experience and workforce engagement. The company works with more than 41,000 healthcare facilities in its mission to reduce patient suffering and enhance caregiver resilience to improve the overall safety, quality, and experience of care. Press Ganey is a PG Forsta company.
About PG Forsta
PG Forsta provides the technology and expertise to help organizations get a deeper, more complete understanding of the experiences of their audiences. The company powers the HX (Human Experience) Platform—a comprehensive experience and research technology platform that breaks down the silos between CX (Customer Experience), Employee Experience (EX), Patient Experience (PX), and Market Research. PG Forsta serves a variety of industries, including healthcare, financial services, hospitality, market research, professional services, retail, and technology.
About Ardent Health Services
Ardent Health Services is a leading provider of healthcare in communities across the country. With a focus on consumer-friendly processes and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, Ardent owns and operates 30 hospitals and 200+ sites of care with more than 1,400 aligned providers in six states. From newly constructed healthcare facilities and expanded services to lifesaving technology and outstanding opportunities for team members, Ardent is committed to providing the resources communities need to keep high quality healthcare close to home.
Health Technology, Healthcare Analytics
PRNewswire | July 18, 2023
Capital Rx, the health technology company changing the way prescription drugs are priced and patients are cared for, and type 2 diabetes (T2D) reversal leader Virta Health have partnered to introduce Rx Reverse. Available to all of Capital Rx's customers, Rx Reverse is a high-touch, provider-led, integrated clinical program designed to help members reverse T2D and fight obesity without costly medications.
The problem is clear: 37+ million Americans have been diagnosed with diabetes, and over 90% of them have T2D (including one-third of the population over 65 years old).1 At the same time, the prevalence of obesity is over 40% of the U.S. population2 and is expected to reach nearly 50% by 2030.3 During a June 15, 2023 webinar, Rethinking Obesity Strategies: The Rise of GLP-1 Drugs and Lifestyle Programs for Weight Loss, Virta revealed new survey data highlighting that diabetes and obesity are the #1 and #2 concerns of health plan leaders in 2023 because of rising costs and downstream health impact.
The launch of Rx Reverse comes as demand for GLP-1 drugs approved for diabetes and weight loss is rising rapidly, and employers and health plan leaders focus on managing the cost of diabetes and obesity. Rx Reverse combines Capital Rx's tech-enabled pharmacy benefit management (PBM) service model, powered by JUDI®, and Virta's solution – personalized nutrition therapy, physician-led deprescription, remote monitoring, and one-on-one coaching – to help health plans reduce costs and improve members' health.
"Leveraging JUDI, our proprietary next-generation claim adjudication platform for Medicare, Medicaid, and commercial plans, we have the ability to seamlessly connect with vendors like Virta, sharing actionable member information efficiently in real-time, and providing the connectivity plan members need to improve their overall health," said Sara Izadi, PharmD, Senior Vice President of Pharmacy at Capital Rx. "Our Single-Ledger Model™, coupled with JUDI's capabilities, enables us to partner with Virta on a solution focused on deprescribing and health equity."
Virta reports lowering HbA1c for patients by 1.3% on average after one year, and 60% of patients enrolled one year attained an HbA1c below 6.5% without using diabetes medications other than metformin. Moreover, patients experience an average of 12% body weight loss at two years. And like Capital Rx, which saves payers 10% - 30% in the first year, on average, after switching from a traditional PBM model, Virta emphasizes positive financial outcomes, including demonstrating an estimated $503 per engaged member per month gross savings for T2D reversal participants.
Three Rx Reverse options are available for plan sponsors to choose from
Type 2 Diabetes Reversal: Helps plan members achieve lower blood sugar – often to sub-diabetes levels <6.5 A1c – and clinically significant weight loss alongside safe deprescription of diabetes medication.
Provider-Led Weight Loss: Helps plan members without diabetes who are considered overweight (BMI ≥ 25) or obese (BMI ≥ 30) achieve clinically significant weight loss.
Type 2 Diabetes Reversal & Provider-Led Weight Loss
"The rapidly rising utilization and cost of obesity and diabetes drugs is putting extreme pressure on healthcare payers," said Kevin Kumler, President at Virta Health. "Capital Rx's tech-forward, value-based approach – a needed evolution from the traditional PBM model – aligns both incentives and systems to help payers control drug costs while members get healthier."
About Virta Health
Virta Health is the leader in type 2 diabetes reversal and is creating a new standard in medical care for people living with type 2 diabetes, prediabetes, or obesity. The company's virtual approach combines personalized nutrition therapy with continuous provider-led support to empower members to eliminate medications, lose weight, and take back their lives. Virta has earned the trust of the nation's largest organizations, including Humana, AutoZone, and Blue Shield of California, delivering industry-leading cost savings of over $6,000 per member per year while putting our fees at risk based on health outcomes.
About Capital Rx
Capital Rx is a healthcare technology company changing the way prescription drugs are priced and patients are cared for in America. As a Certified B Corp™, Capital Rx is executing its mission through a Single-Ledger Model™, the industry's first ethical framework for drug pricing. The company's cloud-native enterprise pharmacy platform, JUDI®, connects every aspect of the pharmacy ecosystem, servicing over 2.4 million members for Medicare, Medicaid, and commercial plans.
GE HealthCare | September 06, 2023
GE HealthCare's latest release is poised to empower healthcare professionals with advanced diagnostic capabilities.
Vscan Air SL aims to aid physicians in expediting the identification and treatment of illnesses.
This portable, wireless ultrasound imaging device will revolutionize cardiac assessments, seamlessly integrating with diverse ultrasound technologies to enhance GE HealthCare's medical equipment.
GE HealthCare has introduced Vscan Air SL, a state-of-the-art medical instrument engineered to enhance the efficiency of healthcare practitioners in diagnosing and treating diverse medical conditions.
Due to its portability and wireless functionality, this device excels at conducting cardiac and vascular assessments directly at the patient's bedside. It leverages single-crystal transducer technology, setting a new standard for
ultrasound imaging precision. By integrating GE HealthCare's SignalMax and XDclear innovations, Vscan Air SL ensures unparalleled image quality and diagnostic accuracy.
This instrument aims to provide remarkable penetration levels, image clarity, and sensitivity, delivering a diagnostic experience of the utmost reliability. Vscan Air SL facilitates the swift acquisition and real-time analysis of high-quality cardiac and vascular images, empowering clinicians with timely insights at the point of care.
With its ability to provide immediate, high-quality imaging, Vscan Air SL assists physicians in making well-informed decisions promptly, thereby enhancing patient care. Its intuitive design streamlines healthcare workflows, enabling quicker and more efficient treatment planning for needy patients. Vscan Air SL alleviates the strain on conventional imaging resources by offering on-the-spot diagnostic capabilities, ensuring that medical professionals can deliver care with greater agility and effectiveness.
"Having ever more powerful handheld ultrasound is a game changer for patient care," said Guy Lloyd, M.D., FRCP, Consultant Cardiologist at Barts Heart Center, University College London Hospitals and Clinical Director for Cardiovascular Diagnostics and Investigations.
GE HealthCare is at the forefront of innovation, working to elevate healthcare delivery standards. The company's intelligent devices, supported by advanced data analytics and harnessing artificial intelligence, profoundly impact millions, facilitating quicker and more informed clinical decisions for healthcare practitioners.
By pushing the boundaries of medical technology and knowledge, the company is leaving an indelible mark on the healthcare industry, propelling it towards a future characterized by heightened precision, advanced digitization, and improved well-being for patients worldwide.
GE HealthCare is a leader in precision care that harmonizes innovation with patient-focused technologies to enhance healthcare. Its commitment is directed toward providing integrated solutions that optimize hospital efficiency, elevate clinician effectiveness, refine therapeutic precision, and improve patient well-being. It aspires to make contributions to the healthcare sphere that transcend traditional limitations.